GRP
EWTX icon

Global Retirement Partners’s Edgewise Therapeutics EWTX Stock Holding History

Global Retirement Partners’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$80 Sell
3
-44
-94% -$1.4K ﹤0.01% 3558
2024
Q3 		$1.25K Buy
+47
New +$935 ﹤0.01% 3086

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Global Retirement Partners's EWTX Position: Q4 2024 in Review

Global Retirement Partners reduced its Edgewise Therapeutics (EWTX) stake by 94% in Q4 2024, selling an estimated $1.4K and leaving 3 shares worth $80. The position accounts for ﹤0.01% of the portfolio, ranked #3558.

Global Retirement Partners first reported a position in EWTX in Q3 2024 and has held it in 2 quarters since. The position peaked at $1.25K in Q3 2024. 200 funds tracked by Wall St. Rank hold EWTX as of Q4 2024.

  • Global Retirement Partners held 3 shares of Edgewise Therapeutics worth $80 as of Q4 2024.
  • Global Retirement Partners sold 44 Edgewise Therapeutics shares in Q4 2024, an estimated $1.4K.
  • Edgewise Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2024, its #3558 holding.
  • Global Retirement Partners first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • Global Retirement Partners's Edgewise Therapeutics position peaked at $1.25K in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.